Insights On Enterprise Solutions
-
Wetting Recommendations For Successful Filter Integrity Testing
1/12/2026
Discover best practices for hydrophobic and hydrophilic filters, troubleshoot failures, and optimize wetting in stainless steel and single-use systems to ensure process reliability and product quality.
-
High-Titer Antibody Expression With 100% pAzF Incorporation At Scale And Minimal Host Toxicity
1/12/2026
Learn how rational design and optimized feed strategies enable high-titer protein expression and full incorporation of non-canonical amino acids at scale, overcoming common toxicity and yield bottlenecks.
-
Increase Agility By Integrating Drug Substance And Drug Product
1/9/2026
Biopharma success depends on agility. Move efficiently from discovery to delivery by co-locating drug substance and drug product operations, reducing transfer risks and accelerating your timeline
-
CDMO Checklist To Choose The Right Aseptic Isolator
1/9/2026
Selecting the right isolator for aseptic filling requires more than comparing features. Discover essential questions to ask and make informed decisions that align with your process and operational goals.
-
The Editors' Roundtable: A 2025 Retrospective Of The Life Science Industry
12/26/2025
In this special edition of “Better Biopharma,” host Tyler Menichiello is joined by fellow chief editors from across the Life Science Connect ecosystem to reflect on the year and share their industry outlooks for 2026.
-
From The Floor At CPHI 2025: Takeaways Everyone Should Know
12/23/2025
Gain insights into evolving pharma priorities, from supply chain resilience to advanced manufacturing, and why flexibility, scalability, and technical expertise matter in a dynamic global market.
-
CDMO Capabilities Overview
12/23/2025
Explore global CDMO capabilities that streamline drug development and manufacturing, leveraging advanced infrastructure and regulatory expertise from early formulation through commercial production.
-
Corporate Overview 2025: Business Strategy & Outlook
12/23/2025
Explore how a growing pharma organization uses innovation, regulatory expertise, and strategic partnerships to deliver targeted therapies and drive impact across the evolving healthcare landscape.
-
State-Of-The-Art CDMO Facility - Maple Grove
12/22/2025
Discover how a U.S.-based CDMO combines advanced infrastructure, quality-driven processes, and flexible manufacturing to support pharmaceutical development and commercial supply.
-
The Impact Of PEGs In The Small Molecule API Market
12/22/2025
Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.